Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
US7964571B2 · kind B2 · utility
62Cited by
1References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 2005 |
| Grant date | Jun 21, 2011 |
| Priority date | — |
| Expiry date | Dec 10, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N15/87
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions comprising a nucleic acid, a gene delivery polymer, and at least one adjunctive chemotherapeutic drug for the treatment of mammalian cancer or hyperproliferative disorders and methods of using thereof for the treatment of mammalian cancer or hyperproliferative disorders by intratumoral, intraperitoneal or systemic injection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.